Literature DB >> 6430627

Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.

A K Trull, G S Panayi.   

Abstract

Serum and salivary IgA antibodies to Klebsiella pneumoniae were estimated by enzyme-linked immunosorbent assay (ELISA) in 53 patients with ankylosing spondylitis (AS) and 30 healthy controls. The concentrations of total serum IgA, salivary secretory component (SC) and serum C-reactive protein (CRP) were also measured. In the serum of AS patients there was a positive correlation between Klebsiella IgA antibodies and the CRP. Salivary anti-Klebsiella IgA was elevated in 39% of AS patients although this was not associated with disease activity. Serum and secretory IgA antibodies to E. coli and Pseudomonas aeruginosa were similar in patients and controls irrespective of disease activity. We conclude that part of the increase in salivary and serum IgA in AS may be due to a specific immune response to Klebsiella in the gastrointestinal tract and that serum antibodies reflect more closely those events associated with active inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6430627     DOI: 10.1007/bf02041551

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

Authors:  T D Kinsella; L Espinoza; F B Vasey
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

2.  Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal.

Authors:  R C Williams; R J Gibbons
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

3.  Role of toxigenic and invasive bacteria in acute diarrhea of childhood.

Authors:  R L Guerrant; R A Moore; P M Kirschenfeld; M A Sande
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

4.  Lymphocytotoxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies: patient and family studies.

Authors:  J Edmonds; D Macauley; A Tyndall; M Liew; K Alexander; A Geczy; H Bashir
Journal:  Arthritis Rheum       Date:  1981-01

5.  Association of inflammation with raised serum IgA in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

6.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

7.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Faecal carriage of klebsiella by patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  R E Warren; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella.

Authors:  M Calguneri; L Swinburne; R Shinebaum; E M Cooke; V Wright
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

10.  Frequency of faecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease.

Authors:  C J Eastmond; H E Willshaw; S E Burgess; R Shinebaum; E M Cooke; V Wright
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

View more
  8 in total

1.  IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.

Authors:  M J Franssen; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

Review 2.  Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Rheumatol Int       Date:  2014-11-11       Impact factor: 2.631

3.  Bacterial antibodies in ankylosing spondylitis.

Authors:  O Mäki-Ikola; K Lehtinen; K Granfors; R Vainionpää; P Toivanen
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

4.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.

Authors:  R Cooper; S M Fraser; R D Sturrock; C G Gemmell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

6.  IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; K Granfors
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

7.  Arthritis risk after acute bacterial gastroenteritis.

Authors:  A X Garg; J E Pope; H Thiessen-Philbrook; W F Clark; J Ouimet
Journal:  Rheumatology (Oxford)       Date:  2008-01-09       Impact factor: 7.580

Review 8.  The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Clin Dev Immunol       Date:  2013-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.